Cargando…

Interspatial Distribution of Tumor and Immune Cells in Correlation with PD-L1 in Molecular Subtypes of Gastric Cancers

SIMPLE SUMMARY: The majority of gastric cancers are negative for the Epstein–Barr virus (EBV) and mismatch repair-proficient, or microsatellite stable. Molecular subtyping currently does not influence clinical decision making, and accurate response prediction towards immunotherapy remains a major ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dislich, Bastian, Mertz, Kirsten D., Gloor, Beat, Langer, Rupert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996833/ https://www.ncbi.nlm.nih.gov/pubmed/35406506 http://dx.doi.org/10.3390/cancers14071736

Ejemplares similares

Programmed death-ligand 1 (PD-L1) expression in primary gastric adenocarcinoma and matched metastases
por: Liu, Drolaiz H. W., et al.
Publicado: (2023)

Surgical pathology of adenocarcinomas arising around or within the gastroesophageal junction
por: Dislich, Bastian, et al.
Publicado: (2022)

Significance of tumour regression in lymph node metastases of gastric and gastro‐oesophageal junction adenocarcinomas
por: Reim, Daniel, et al.
Publicado: (2020)

The Membrane-Bound Aspartyl Protease BACE1: Molecular and Functional Properties in Alzheimer’s Disease and Beyond
por: Dislich, Bastian, et al.
Publicado: (2012)

Immune profiles according to EGFR mutant subtypes and correlation with PD-1/PD-L1 inhibitor therapies in lung adenocarcinoma
por: Koh, Young Wha, et al.
Publicado: (2023)

Prognostic relevance of autophagy markers LC3B and p62 in esophageal adenocarcinomas
por: Adams, Olivia, et al.
Publicado: (2016)

Favourable long-term survival of patients with esophageal cancer treated with extended transhiatal esophagectomy combined with en bloc lymphadenectomy: results from a retrospective observational cohort study
por: Kröll, Dino, et al.
Publicado: (2020)

Immunohistochemical Study of Bladder Cancer Molecular Subtypes and Their Association with PD-L1 Expression
por: Goutas, Dimitrios, et al.
Publicado: (2022)

Discovery of New Molecular Subtypes in Oesophageal Adenocarcinoma
por: Berg, Daniela, et al.
Publicado: (2011)

The heterogeneity of PD-L1 protein in gastric cancer: expression and distribution characteristics
por: Wang, Yuejun, et al.
Publicado: (2022)

Consensus Molecular Subtypes Efficiently Classify Gastric Adenocarcinomas and Predict the Response to Anti-PD-1 Immunotherapy
por: Wu, Xiangyan, et al.
Publicado: (2022)

Study of PD-L1 Expression with Association of Pathological Factors and Molecular Subtypes in Breast Carcinoma
por: Gupta, Abhishek, et al.
Publicado: (2022)

Identification hub genes of consensus molecular subtype correlation with immune infiltration and predict prognosis in gastric cancer
por: Yu, Xin, et al.
Publicado: (2021)

Profiles of PD-1, PD-L1, PD-L2 in Gastric Cancer and Their Relation with Mutation, Immune Infiltration, and Survival
por: Liu, Jingwei, et al.
Publicado: (2020)

Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypes
por: Li, Huili, et al.
Publicado: (2020)

Her2-Targeted Therapy Induces Autophagy in Esophageal Adenocarcinoma Cells
por: Janser, Félice A., et al.
Publicado: (2018)

Direct prediction of genetic aberrations from pathology images in gastric cancer with swarm learning
por: Saldanha, Oliver Lester, et al.
Publicado: (2022)

Identification and validation of stromal-tumor microenvironment-based subtypes tightly associated with PD-1/PD-L1 immunotherapy and outcomes in patients with gastric cancer
por: Ren, Qianqian, et al.
Publicado: (2020)

Combined PD-1/PD-L1 and tumor-infiltrating immune cells redefined a unique molecular subtype of high-grade serous ovarian carcinoma
por: Liu, Ping, et al.
Publicado: (2022)

Clinical Scenarios Emerging from Combined Immunophenotypic, Molecular and Morphologic Analysis of Pancreatic Cancer: The Good, the Bad and the Ugly Scenario
por: Karamitopoulou, Eva, et al.
Publicado: (2019)

CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity
por: Straub, Melanie, et al.
Publicado: (2016)

Correction to: Identification hub genes of consensus molecular subtype correlation with immune infiltration and predict prognosis in gastric cancer
por: Yu, Xin, et al.
Publicado: (2021)

Characterization of Immune-Related Molecular Subtypes and a Prognostic Signature Correlating With the Response to Immunotherapy in Patients With Gastric Cancer
por: Wang, Gaoming, et al.
Publicado: (2022)

The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors
por: Chen, Li, et al.
Publicado: (2022)

Molecular Features Distinguish Gastric Cancer Subtypes
por: De Re, Valli
Publicado: (2018)

Genomic alteration profile and PD‐L1 expression among different breast cancer subtypes in Chinese population and their correlations
por: Li, Kai, et al.
Publicado: (2022)

Prediction of Two Molecular Subtypes of Gastric Cancer Based on Immune Signature
por: Wu, Dan, et al.
Publicado: (2022)

PD-L1 as a Prognostic Factor in Early-Stage Colon Carcinoma within the Immunohistochemical Molecular Subtype Classification
por: Azcue, Pablo, et al.
Publicado: (2021)

Optimized PD-L1 scoring of gastric cancer
por: Schoemig-Markiefka, Birgid, et al.
Publicado: (2021)

Adversarial attacks and adversarial robustness in computational pathology
por: Ghaffari Laleh, Narmin, et al.
Publicado: (2022)

Genomic alterations and molecular subtypes of gastric cancers in Asians
por: Ye, Xiang S., et al.
Publicado: (2016)

PD-L1 pitfalls: Emphasizing the importance of membranous localization and correlation with tumor cell and macrophage distributions
por: Mills, Anne M., et al.
Publicado: (2017)

Distribution of breast cancer subtypes among Jordanian women and correlation with histopathological grade: molecular subclassification study
por: Shomaf, Maha, et al.
Publicado: (2013)

Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology
por: Cisło, Magdalena, et al.
Publicado: (2018)

Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer
por: Imai, Yushi, et al.
Publicado: (2020)

A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas
por: Adams, Olivia, et al.
Publicado: (2018)

Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas
por: Adams, Olivia, et al.
Publicado: (2019)

Baseline monocyte and its classical subtype may predict efficacy of PD-1/PD-L1 inhibitor in cancers
por: Shao, Yilin, et al.
Publicado: (2021)

PD-L1 and PD-1 expression correlate with prognosis in extrahepatic cholangiocarcinoma
por: Ma, Ke, et al.
Publicado: (2017)

Prognostic Value of PD-L1 Immunohistochemical Marker in Gastric Carcinoma and Its Correlation with HER2 Status
por: Attia, Samar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9v5revcdak19a486hi72pet4tu